EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child

Nathan P Wiederhold iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01072-25 ↗

Kurz gefasst

Kommentar in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Nathan P Wiederhold. Beteiligte Einrichtung: Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, University of Texas Science Center at San Antonio, San Antonio, Texas, US…. Hauptthemen laut MEDLINE: Antifungal Agents, Ascomycota, Drug Resistance, Multiple, Fungal, Mycoses. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lomentospora prolificans is a multi-drug-resistant filamentous fungus that can cause invasive disease in both immunocompromised and immunocompetent hosts. Current treatment options are limited. Olorofim is an investigational antifungal that demonstrates activity against several different molds, including many that are resistant to other antifungals. The case presented by Fortini et al. (Antimicrob Agents Chemother 69:e00602-25, 2025, https://doi.org/10.1128/aac.00602-25 ) describes the successful use of olorofim treatment in an 8-year-old who suffered from Lomentospora prolificans tendonitis, synovitis, and osteomyelitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsAscomycotaDrug Resistance, Multiple, FungalMycosesChildHumansMicrobial Sensitivity TestsOsteomyelitisCase Reports as Topic

Stichwörter der Autor:innen

Lomentospora prolficanscase reportchildmultidrug resistanceolorofim

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, University of Texas Science Center at San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Nathan P Wiederhold

Zitieren

APA

Wiederhold, N. P. (2025). Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01072-25

Vancouver

Wiederhold NP. Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01072-25

BibTeX
@article{Wiederhold2025,
  author = {Wiederhold, Nathan P},
  title = {Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01072-25}
}
Kostenlos starten →